Description
recoveryELISA TNFα Neutralization Rate/Infliximab Kit (RTI) | R444 | BioTeZ
Product Features:
Type: ELISA
Reactivity : Infliximab and free TNF alpha
Antigen : Infliximab and free TNF alpha
Detection Range : 0.1 – 15 µg/mL Infliximab; TNF alpha in sample without Infliximab: 2-400ng/ml;TNF alpha in sample with Infliximab: 1-160ng/ml
Application : The unique recoveryELISA technology monitors parallel the free drug Infliximab, the free antigen TNF alpha concentration and the neutralization rate of TNF alpha in patient sera during Infliximab therapy.
Description : The unique recoveryELISA technology monitors parallel the free drug Infliximab, the free antigen TNF alpha concentration and the neutralization rate of TNF alpha in patient sera during Infliximab therapy. This next generation therapeutic drug monitoring tool can be used by diagnostic laboratories and medical doctors for research to find a personalized medication dose for each patient individually.
Research Area : Therapies and studies with Infliximab, Rheumatic Diseases
Specificity : Infliximab and free TNF alpha
Immunogen : N/A
Sensitivity : Infliximab: 0.1 µg/mL; TNF alpha in sample without Infliximab: 2ng/ml;TNF alpha in sample with Infliximab: 1ng/ml
Predicted Reactivity : Infliximab and free TNF alpha
Cross Reactivity : N/A
Minimum Shelf life time in months : 6 months
Storage Shipping Temp Min : ice pack to temperature >25°C
Storage Shipping Temp Max : 37°C
Storage Long Term : 2-8°C
Principle : Sandwich-ELISA
Components : microplate, buffers, antibody conjugate, standards, TMB reagent, stopping solution
Characteristics : Kit
Sample Type :
Format : 96 well microplate